SHAPING THE WORLD – A pivotal moment in research and innovation for global health

Download Programme

Innovation underpins successful societies, sustainable growth and global health. The UN Sustainable Development Goals seek the end of epidemics of HIV/AIDS, TB, malaria and other neglected infectious diseases. These diseases kill nearly seven million people each year, often due to a lack of effective tools for prevention, diagnosis and treatment. Without these missing tools – without innovation – we will never achieve sustainable development and health for all.

Neglected diseases affect the world’s poorest people. Solutions must therefore come by bringing together the funding of the public and philanthropic sectors and the ingenuity and creativity of the private sector, universities and researchers, who develop transformative technologies and build understanding that can change the future of global health.

The conclusions of the 2016 G-FINDER report, to be launched at the event, provide policymakers, funders, researchers and industry with an understanding of how neglected disease research and development is funded around the world. Conducted by Policy Cures Research and funded by the Bill and Melinda Gates Foundation, the G-FINDER project has tracked and reported on investment into neglected disease R&D since 2008. It provides a unique window into the shifting global funding landscape for innovation in global health, helping to determining the next steps for R&D in Europe and the world.

  • What does the latest information on the unprecedented global response to the Ebola epidemic tell us about how innovation for global health can be supported?
  • How can Europe and the rest of the global health community make decisions about the role they will play in supporting innovation to address the health Sustainable Development Goals?
  • How can the future EU research framework programme be relevant, credible and stimulate innovation in the field of global health?
  • How can durable sustainable private, public and philanthropic funding for global health research and innovation be encouraged from Europe and the world?



Should you not be able to see the playlist please click here.

Photo Gallery

Shaping the world - A pivotal moment in research for global health

Should you not be able to see the gallery, please click here.

Related content

You may wish to view the event report.

IMAGE CREDIT: Satenik Guzhanina/


11.00 – 11.30 Welcome coffee and registration of participants
11.30 – 13.00 G-Finder Report launch and Policy Insight debate
13.00 End of debate

Moderated by
Tamsin Rose / Senior Fellow at Friends of Europe


  • Bill Gates

    Co-Chair of the Bill and Melinda Gates Foundation
    Known for co-founding with Paul Allen one of the world’s largest software business, Microsoft, Bill Gates established the Bill & Melinda Gates Foundation with his wife in 2000. Together they shape and approve grant-making strategies, advocate for the foundation’s issues and help to set the overall direction of the organisation. Bill Gates works to expand opportunity to the world’s most disadvantaged people by collaborating with grantees and partners, tackling international and domestic issues, such as health and education. In 2016, Gates and his wife Melinda were recognized for their philanthropic work when they were named recipients of the Presidential Medal of Freedom, presented by former U.S. President Barack Obama.

  • Nick Chapman

    Executive Director of Policy Cures Research
    Nick Chapman has over 10 years of experience in health policy and practice as a doctor, research associate and analyst. Working on projects for governments, major philanthropic organisations and public-private partnerships, Chapman’s experience includes strategy development, funding gap analysis and innovative financing mechanisms. He has also played an active role in Policy Cures’ efforts to raise the profile of global health R&D.

  • Catharina Boehme

    Chief Executive Officer at the Foundation for Innovative New Diagnostics
    Leading the Foundation for Innovative New Diagnostics (FIND), Catharina Boehme oversees an organisation which enables the development and delivery of much-needed diagnostic tests for diseases of poverty. She also serves as co-Chair of the New Diagnostics Working Group of the Stop Tuberculosis (TB) Partnership, and is a member of the World Health Organisation (WHO) Strategic and Technical Advisory Group (STAG-TB). Before joining FIND in 2005, Boehme established a TB research unit at Mbeya Medical Research Program in Tanzania.

  • Luc Debruyne

    President of Global Vaccines at GlaxoSmithKline (GSK)
    As President of Global Vaccines at GlaxoSmithKline (GSK), Luc Debruyne aims to lead the industry in improving health globally. Today, GSK Vaccines delivers broad portfolio of more than 30 different vaccines to 90% of the world’s countries. Debruyne is a member of the Vaccines CEO Roundtable convened by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and a member of the Management Committee of the Belgian Federation of Enterprises.

  • Ruxandra Draghia-Akli

    European Commission Deputy Director General for Research and Innovation
    Ruxandra Draghia-Akli serves as the European Commission representative on the Governing Boards of most Joint Technology Initiatives of the EU within different industrial sectors. A globally recognised leader in the field of nucleic acid delivery for therapeutic and vaccination applications, she is also an inventor and has submitted over a hundred patent applications. Before joining the Commission, Draghia-Akli worked in biotechnology companies, including as Vice-President, managing research programmes in the areas of gene therapy and DNA vaccination.

  • Tamsin Rose

    Non-Resident Fellow at Friends of Europe
    Tamsin Rose is a Senior Fellow at Friends of Europe. She is also a member of the external speaker team for the European Commission Directorate General for Communication, describing how the EU works and key policies to visitor groups from around the world. Since 2002, Rose has specialised in public health and public participation issues, serving as Secretary General of the European Public Health Alliance (EPHA), and providing strategic advice for health groups on how to engage with the EU.

  • Carlos Moedas

    European Commissioner for Research, Science and Innovation
    Prior to his current position, Carlos Moedas worked for Goldman Sachs and the Deutsche Bank before establishing his own investment management company in 2008. In the midst of the European sovereign debt crisis, Moedas was appointed as lead coordinator of the Portuguese Social Democratic Party in the negotiations to set up the 2011 state budget and later became chief negotiator for Portugal’s economic and financial adjustment programme. European Commissioner since 2014, Moedas focuses on the promotion and implementation of Horizon 2020, the biggest EU Research and Innovation programme, aiming to make progress towards promoting international excellence in research and science in the EU.



More events